Tag Archives: USPTO

USPTO Post-Prosecution Pilot Program Launches

A guest post from Edward Sandor, attorney at Schwegman. The Post-Prosecution Pilot Program (P3) launched at the USPTO Monday, combining features of the AFCP 2.0 and Pre-Appeal Brief Conference Pilot programs, with the notable addition of Applicant participation in the process. … Continue reading

Posted in USPTO Practice and Policy | Tagged , , , , , | Leave a comment

USPTO will “Fast Track” Cancer Immunotherapy Applications

On June 29, 2016, Director Lee promulgated rules to implement a one-year pilot program to effectively grant “Fast Track” status to applications with at least one claim to treating cancer using immunotherapy. (A copy of this document can be found … Continue reading

Posted in USPTO Practice and Policy | Tagged , , , , , , , | Leave a comment

Same-Day Continuing Applications are Co-pending under s. 120

The outcome of this question of statutory construction was not really in doubt, given the fact that an adverse holding could invalidate thousands of patents which needed same-day copendency to avoid intervening prior art. Immersion Corp. v. HTC Corp., Appeal no. … Continue reading

Posted in Statutory Interpretation | Tagged , , , , , , , , | Leave a comment

Due May 24 — Comments On Improving Patent Quality Metrics

Many patent attorneys received a notice recently, copied below, alerting them to efforts by the US Patent Office to improve patent quality. The notice references a “Master Review Form”. A preliminary version can be found at: http://www.uspto.gov/sites/default/files/documents/MRF.pdf Not only does … Continue reading

Posted in Patentable Subject Matter | Tagged , , , , | Leave a comment